Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
---|
11/19/2003 | EP1196153B1 Process for the improvement of spermatozoa fertilization activity |
11/19/2003 | CN1456665A Production of organic phosphorous chemicals decomposing enzyme by silkworm bioreactor |
11/19/2003 | CN1127897C Special apparatus for raising crocodile |
11/18/2003 | US6649811 Use of nimesulide for the preparation of a pharmaceutical formulation for treating a neurodegenerative condition |
11/18/2003 | US6649385 Isolated nucleic acid molecules encoding human squalene synthase proteins, and related products and processes |
11/17/2003 | CA2387006A1 A novel mouse with deficiency of gene of neutrophil chemotactic factor lect2 |
11/13/2003 | WO2003093442A2 Cell cultures from animal models of alzheimer's disease for screening and testing drug efficacy |
11/13/2003 | WO2003093436A2 Treatment for phenylketonuria |
11/13/2003 | WO2003093414A2 Transgenic animal model for spliceosome-mediated rna trans-splicing |
11/13/2003 | WO2003093296A2 Kinase anchor protein muteins, peptides thereof, and related methods |
11/13/2003 | WO2003092715A2 Proteins involved in the regulation of energy homeostasis |
11/13/2003 | WO2003092612A2 VECTORS HAVING BOTH ISOFORMS OF β-HEXOSAMINIDASE |
11/13/2003 | WO2003092370A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
11/13/2003 | WO2003092368A1 Method and device for injecting at least one product in an egg for treating the embryo |
11/13/2003 | WO2003092367A1 Apparatus for detecting estrus in livestock |
11/13/2003 | WO2003068968A3 Mutated gene coding for a lat protein and the biological applications thereof |
11/13/2003 | WO2003028536A3 Methods for diagnosing and treating heart disease |
11/13/2003 | WO2003020164A3 Arthropod diet delivery system |
11/13/2003 | WO2003011171A3 Apparatus for detecting estrus in livestock |
11/13/2003 | WO2003000889A3 Identification of ses-1 and the uses of the same |
11/13/2003 | WO2002097056A3 Method for generating replication defective viral vectors that are helper free |
11/13/2003 | WO2002057290A8 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes |
11/13/2003 | WO2001090313A8 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS |
11/13/2003 | US20030213008 Method to produce cloned embryos and adults from cultured cells |
11/13/2003 | US20030213007 Xenogenic transplantation of human milk producing tissues into cleared mammary fat pads of cattle; producing milk for infants |
11/13/2003 | US20030213005 Genetically engineered nonhuman animal model coding lethal alleles which function in controlling the population of transgenic animal |
11/13/2003 | US20030213004 Composition comprising ribozyme/monoclonal antibody fusion protein for treating cell proliferative disorders; anticarcinogenic/antiproliferative agents |
11/13/2003 | US20030213003 Preparing and recoverng genetically engineered fusion protein for treating diabetes |
11/13/2003 | US20030213002 Extensive myocardial infarction model animal, method for preparation there of, and application for drug screening and regenerative medicine |
11/13/2003 | US20030212262 Human serine racemase |
11/13/2003 | US20030211549 Functional proteins and therapeutic and diagnostic methods for use thereof |
11/13/2003 | US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
11/13/2003 | US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents |
11/13/2003 | CA2485038A1 Transgenic animal model for spliceosome-mediated rna trans-splicing |
11/13/2003 | CA2484920A1 Human chronic lymphocytic leukemia modeled in mouse by targeted tcl1 expression |
11/13/2003 | CA2484676A1 Kinase anchor protein muteins, peptides thereof, and related methods |
11/13/2003 | CA2483915A1 Vectors having both isoforms of b-hexosaminidase |
11/12/2003 | EP1361270A2 Disruption of the REDK gene |
11/12/2003 | EP1361269A1 Delivery of gene products via mesangial cells expressing an exogenous gene |
11/12/2003 | EP1360965A1 Methods of treating diseases in association with decrease in the expression of aop-1 gene or aop-1 and remedies for the diseases |
11/12/2003 | EP1360898A1 Joint utilization of the insulin gene and the glucokinase gene in the development of therapeutic approaches for diabetes mellitus |
11/12/2003 | EP1360293A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
11/12/2003 | EP1360287A1 Methods of modifying eukaryotic cells |
11/12/2003 | EP1360279A2 Novel form of the phgpx protein as a diagnostic marker for male infertility |
11/12/2003 | EP1360199A2 Treatment involving dkk-1 or antagonists thereof |
11/12/2003 | EP1359797A1 Human sphingosine-1-phosphate phosphatase |
11/12/2003 | EP1112083B1 Use of an angiogenic factor for the treatment of microvascular angiopathies |
11/12/2003 | EP0741515B1 Transgenic production of antibodies in milk |
11/12/2003 | CN2585559Y Control sleeve for queen bee ovipositting |
11/11/2003 | US6646109 Antibody that binds specifically; blocked by nicotine |
11/06/2003 | WO2003091433A1 EXPRESSION SYSTEMS FOR STEM LOOP RNA MOLECULE HAVING RNAi EFFECT |
11/06/2003 | WO2003090689A2 Neurodegenerative disorder treatment using gdnf secreting neural cells |
11/06/2003 | WO2003090526A1 Production of cloned offspring from cooled carcasses |
11/06/2003 | WO2003068153A3 CARDIAC-SPECIFIC 11β HYDROXYSTEROID DEHYDROGENASE TYPE 2 TRANSGENIC MICE |
11/06/2003 | WO2003031939A3 Protein modification and maintenance molecules |
11/06/2003 | WO2003027263A3 Proteins associated with cell growth, differentiation, and death |
11/06/2003 | WO2002081741A3 Use of products of genes of the 2'-5' oligoadenylate synthetase family (oas) for screening antiviral agents and for detecting responsiveness to flaviviridae infection |
11/06/2003 | WO2002074078B1 Method for embryo after impregnation of the recipient female |
11/06/2003 | WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
11/06/2003 | WO2002024891A9 B7-like molecules and uses thereof |
11/06/2003 | WO2001080633A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
11/06/2003 | WO2000023569A8 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
11/06/2003 | US20030208786 Transgenic pig containing heat shock protein 70 transgene |
11/06/2003 | US20030208785 Transgenic pig containing heat shock protein 70 transgene |
11/06/2003 | US20030208783 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
11/06/2003 | US20030208781 By immunization with any desired antigen |
11/06/2003 | US20030207450 Derived from the neuroretina of the eye ex vivo and in vivo |
11/06/2003 | US20030207447 Used to distinguish between arterial endothelial cells (arteries) and venous endothelial cells (veins) |
11/06/2003 | US20030207443 A harvesting device which is suitable for use with waste treatment apparatus of the type including an elevated main body supporting a base composed of a plurality of spaced-apart parallel support elements defining the bottom of a treatment |
11/06/2003 | US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders |
11/06/2003 | US20030207347 Useful in treating ovarian, renal, neurological, cardiovascular disorders and modulating angiogenesis, cell proliferation |
11/06/2003 | US20030206889 Methods of treating anemia using recombinant adeno-associated virus virions |
11/06/2003 | CA2484223A1 Use of human neural stem cells secreting gdnf for treatment of parkinson's and other neurodegenerative diseases |
11/06/2003 | CA2484079A1 Expression systems for stem-loop rna molecule having rnai effect |
11/06/2003 | CA2483387A1 Production of cloned offspring from cooled carcasses |
11/05/2003 | EP1358353A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
11/05/2003 | EP1358334A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
11/05/2003 | EP1358317A1 Activation of nuclear transfer embryos |
11/05/2003 | EP1358208A2 Sequences upstream of the carp gene, vectors containing them and uses thereof |
11/05/2003 | EP1357790A2 Method for identifying genes involved in cell proliferation |
11/05/2003 | EP0994945B1 Smad-interacting polypeptides and their use |
11/05/2003 | EP0489058B1 Cystic fibrosis gene |
11/05/2003 | CN2583981Y Moving needle for bee-keeping |
11/05/2003 | CN2583980Y Pad for inducing bowl evacuation of pet |
11/05/2003 | CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
11/05/2003 | CN1453245A Method of producing organic fertilizr with earthworm excrement |
11/04/2003 | US6642478 Method for forming a via hole, flexible wiring board using the method, and method for producing the flexible wiring board |
11/04/2003 | US6642369 Nucleic acids involved in the responder phenotype and applications thereof |
11/04/2003 | CA2242185C High efficiency vermiculture process and apparatus |
10/30/2003 | WO2003089638A1 Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof |
10/30/2003 | WO2003089632A1 Gfp-transfected clon pig, gt knock-out clon pig and methods for production thereof |
10/30/2003 | WO2003089630A1 Methods for producing immortalised antibodies-secreting cells |
10/30/2003 | WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
10/30/2003 | WO2003089609A2 Short fragment homologous replacement to provide bse resistant cattle |
10/30/2003 | WO2003089583A2 Tissue specific genes and gene clusters |
10/30/2003 | WO2003089580A2 Cancer models |
10/30/2003 | WO2003088924A2 Phosphoinositide 3-kinase mediated inhibition of gpcrs |
10/30/2003 | WO2003073841A3 Transgenic non-human mammals expressing constitutively activated tyrosine kinase receptors |
10/30/2003 | WO2003059923A3 Methods and compositions for generating a genetically modified animal using lentiviral vectors |
10/30/2003 | WO2003038045A3 Acid phosphatase (acp1) gene as a susceptibility locus for hyperlipidemia |